Naphazoline hydrochloride 0.3 MG/ML / propylene glycol 10 MG/ML Ophthalmic Solution — RxCUI 2627786
RxNorm drug concept · Semantic clinical drug
RxCUI 2627786
Semantic clinical drug · SCD
● Current RxNorm concept 2 FDA products
4 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI2627786
Official nameNaphazoline hydrochloride 0.3 MG/ML / propylene glycol 10 MG/ML Ophthalmic Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asnaphazoline hydrochloride 0.03 % / propylene glycol 1 % Ophthalmic Solution
FDA products mapped2
Package NDCs mapped4
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
🕸️ Concept Web — How Naphazoline hydrochloride 0.3 MG/ML / propylene... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Naphazoline hydrochloride 0.3 MG/ML / propylene glycol 10 MG/ML Ophthalmic Solution
RxCUI 2627786 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 4
The active substance itself — no strength, form, or brand attached yet.
-
Naphazoline
7247IN -
Propylene glycol
34693IN -
Naphazoline / propylene glycol
2627783MIN -
Naphazoline hydrochloride
82054PIN
-
Naphazoline
-
Dose forms 6
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Naphazoline / propylene glycol Ophthalmic Solution
2627785SCDF -
Naphazoline hydrochloride / propylene glycol Ophthalmic Solution
2649389SCDFP -
Naphazoline / propylene glycol Ophthalmic Product
2627784SCDG -
Naphazoline hydrochloride / propylene glycol Ophthalmic Product
2659469SCDGP -
Ophthalmic Solution
7670DF -
Ophthalmic Product
1151135DFG
-
Naphazoline / propylene glycol Ophthalmic Solution
-
Clinical & branded drugs 2
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Naphazoline hydrochloride 0.3 MG/ML
1046650SCDC -
Propylene glycol 10 MG/ML
402606SCDC
-
Naphazoline hydrochloride 0.3 MG/ML
Showing up to 8 concepts per family — 12 of 12 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Naphazoline hydrochloride 0.3 MG/ML
SCDC · 1046650 -
Propylene glycol 10 MG/ML
SCDC · 402606 -
Naphazoline / propylene glycol Ophthalmic Solution
SCDF · 2627785 -
Naphazoline hydrochloride / propylene glycol Ophthalmic Solution
SCDFP · 2649389 -
Naphazoline / propylene glycol Ophthalmic Product
SCDG · 2627784 -
Naphazoline hydrochloride / propylene glycol Ophthalmic Product
SCDGP · 2659469
📦 FDA Products & Package NDCs
2 products · 4 package NDCs
4 package NDCs map to RxCUI 2627786 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 82864-0001-01 | 1 BOTTLE, DROPPER in 1 CARTON (82864-001-01) / 15 mL in 1 B... | Revitalize Energizing Eye Drops | Revitalize Energy Inc. | 2023-02-01 |
| 82864-0001-05 | 1 BOTTLE, DROPPER in 1 CARTON (82864-001-05) / 5 mL in 1 BO... | Revitalize Energizing Eye Drops | Revitalize Energy Inc. | 2025-01-16 |
| 85211-0001-01 | 1 BOTTLE, DROPPER in 1 CARTON (85211-001-01) / 5 mL in 1 BO... | Droptics Performance Eye Drops | Droptics LLC | 2025-03-22 |
| 85211-0001-02 | 1 BOTTLE, DROPPER in 1 CARTON (85211-001-02) / 7 mL in 1 BO... | Droptics Performance Eye Drops | Droptics LLC | 2025-11-28 |
Observed labelers:
Droptics LLC (2) ·
Revitalize Energy Inc. (2)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.